These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8782658)

  • 1. Inhibition of methionine uptake by cis-diamminedichloroplatinum (II) in experimental brain tumors.
    Mineura K; Sasajima T; Sasajima H; Kowada M
    Int J Cancer; 1996 Sep; 67(5):681-3. PubMed ID: 8782658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic analysis of (14C-methyl)-L-methionine uptake in transplanted rat brain tumors.
    Sasajima T; Mineura K; Kuwahara N; Kowada M; Murakami M; Uemura K
    Noshuyo Byori; 1993; 10(1):7-9. PubMed ID: 8220785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (14C-methyl)-L-methionine uptake in rat brain tumors before and after treatment with the protein synthesis inhibitor cycloheximide.
    Mineura K; Sasajima T; Kuwahara N; Kowada M; Murakami M; Uemura K
    J Neurooncol; 1993 Mar; 15(3):229-33. PubMed ID: 8360708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity.
    Reser D; Rho M; Dewan D; Herbst L; Li G; Stupak H; Zur K; Romaine J; Frenz D; Goldbloom L; Kopke R; Arezzo J; Van De Water T
    Neurotoxicology; 1999 Oct; 20(5):731-48. PubMed ID: 10591510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracarotid recombinant human tumor necrosis factor-alpha reduces cerebral blood flow and methionine uptake in rat brain tumors.
    Sasajima T; Mineura K; Kowada M; Hatazawa J; Miura S
    J Neurooncol; 1997 Sep; 34(2):123-9. PubMed ID: 9210058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy.
    Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR
    Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells.
    Scanlon KJ; Safirstein RL; Thies H; Gross RB; Waxman S; Guttenplan JB
    Cancer Res; 1983 Sep; 43(9):4211-5. PubMed ID: 6683587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C epsilon translocation and phosphorylation by cis-diamminedichloroplatinum(II) (CDDP): potential role in CDDP-mediated cytotoxicity.
    Ohmori T; Arteaga CL
    Cell Growth Differ; 1998 Apr; 9(4):345-53. PubMed ID: 9563854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
    Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
    Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
    Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.
    Ito M; Yamamoto S; Nimura K; Hiraoka K; Tamai K; Kaneda Y
    J Gene Med; 2005 Aug; 7(8):1044-52. PubMed ID: 15756713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
    Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of polyamine analog-induced enhancement of cisplatin cytotoxicity in the U-251 MG human malignant glioma cell line.
    Paliwal J; Janumpalli G; Basu HS
    Cancer Chemother Pharmacol; 1998; 41(5):398-402. PubMed ID: 9523736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of polyamine analogues to induce Z-DNA structure in synthetic polynucleotides in vitro inversely correlates with their effects on cytotoxicity of cis-diaminedichloroplatinum (II) (CDDP) in human brain tumor cell lines.
    Basu HS; Pellarin M; Feuerstein BG; Marton LJ
    Anticancer Res; 1996; 16(1):39-47. PubMed ID: 8615642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer].
    Nakagawa H; Yamada M; Tamura M; Yoshida M; Shindo M; Nishiyama H; Sakai S
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):317-24. PubMed ID: 24743276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
    Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
    Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
    Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.